When should we tell patients there may be no blood? Evaluating the 'informed' consent process.

Booth, Garrett S; Jacobs, Jeremy W; Stephens, Laura D; Chooljian, David M; Savani, Bipin N; Gehrie, Eric A

Booth, Garrett S; Jacobs, Jeremy W; Stephens, Laura D; Chooljian, David M; Savani, Bipin N; Gehrie, Eric A.

Afiliación

Booth GS; The Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Jacobs JW; Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Stephens LD; Department of Pathology, University of Arizona College of Medicine, Tucson, Arizona, USA.
Chooljian DM; Ethics Consultation Service & Pulmonary Section, Medical Service, Veterans Affairs Loma Linda Healthcare System, Loma Linda, California, USA.
Savani BN; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Loma Linda University School of Medicine, Loma Linda, California, USA.
Gehrie EA; Department of Medicine, Hematology, Stem Cell Transplantation and Cellular Therapy Section, Division of Hematology/Oncology, Vanderbilt University Medical Center and Veterans Affairs Medical Center, Nashville, Tennessee, USA.

Br J Haematol ; 198(1): e8-e10, 2022 07.

Article en En | MEDLINE | ID: mdl-35315509

Asunto(s)

Consentimiento Informado; Relaciones Médico-Paciente; Humanos

Palabras clave

consent; pandemic; supply chain; transfusion

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Relaciones Médico-Paciente / Consentimiento Informado Límite: Humans Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google